Teladoc Inc.’s TDOC fourth-quarter 2015 operating loss of 39 cents per share was lower than the Zacks Consensus Estimate of a loss of 41 cents.
The company incurred loss in the quarter due to a two-fold rise in its operating expenses that outpaced revenue growth.
Total revenue during the quarter came in at $22.6 million, up 75%.
Revenues from subscription access fees surged 70% to $18 million and revenues from visit fees soared 97% to $4.6 million.
Total operating expenses were $30.5 million compared with $15.4 million in the year-ago quarter. The increase was driven by higher advertising, sales, technology and development, general and administrative as well as depreciation and amortization expenses.
Teladoc’s total membership increased 51% year over year to 12.2 million.
Total visits of 184,000 surged 67% year over year.
Financial Position
Teldoc’s total assets were $229.7 million, up from $92 million as of Dec 31, 2014.
Total cash, cash equivalents and marketable securities were $55.1 million at the end of the quarter, up from $46.4 million as of Dec 31, 2014.
Guidance
For first-quarter 2016, the company expects revenues in the range of $26–$27 million. While EBITDA is projected in the range of a loss of $13 million to a loss of $14 million, adjusted EBITDA is estimated in the range of a loss of $11 million to a loss of $12 million. Membership will be approximately 14.5–15 million as of Mar 31, 2016. Teladoc anticipates total visits to be between 220,000 and 230,000. Also, first-quarter net loss per share, based on 38.6 million weighted average shares outstanding, is projected between $0.36 and $0.38.
Teladoc provided the guidance for full-year 2016 as well. Revenues are projected in the range of $118–$122 million. EBITDA is expected in the range of a loss of $42 million to a loss of $44 million. Adjusted EBITDA is estimated in the range of a loss of $31 million to a loss of $33 million. Guidance for membership lies in the range of 16.5 million to 17.5 million as of Dec 31, 2016. Total visits are likely to be between 880,000 and 900,000. Net loss per share, based on 39.0 million weighted average shares outstanding, is expected to be between $1.26 and $1.33.
Notably, this was the third quarter as a publicly traded company for Teladoc, the first and largest telehealth provider in the nation. The company, which was founded in 2002, launched its IPO in Jun, 2015. Teladoc is renowned for clinical quality and patient satisfaction, which will enable it to maintain its leading position in the rapidly growing telemedicine industry.
During the quarter, Teladoc was selected by New Jersey-based leading non-profit health care organization Meridian Health. Per the deal, Teladoc will offer its telehealth services to residents in the areas where Meridian serves. Last month, East Jefferson General Hospital selected Teladoc to deliver affordable, comprehensive quality care via telehealth to residents in New Orleans.
Teladoc holds a Zacks Rank # 2 (Buy). Other stocks worth considering that hold the same Zacks Rank as Teladoc are Cancer Genetics, Inc. CGIX, Charles River Laboratories International, Inc. CRL and Civitas Solutions, Inc. CIVI.